WO2000043538A1 - PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF - Google Patents
PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF Download PDFInfo
- Publication number
- WO2000043538A1 WO2000043538A1 PCT/CA2000/000047 CA0000047W WO0043538A1 WO 2000043538 A1 WO2000043538 A1 WO 2000043538A1 CA 0000047 W CA0000047 W CA 0000047W WO 0043538 A1 WO0043538 A1 WO 0043538A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oligonucleotide
- antisense
- oligonucleotides
- sense
- hybridization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Definitions
- the present invention relates to a process for the generation oligonucleotide librairies (OLs) representative of genomes or expressed mRNAs (cDNAs) and to the uses thereof.
- the present invention relates to a process for the generation of oligonucleotide librairies comprising oligonucleotides of uniform length.
- the present invention further relates to the uses of these OLs in numerous biotechnological applications, including the identification and/or characterization of biological materials, clinical diagnosis (DNA/RNA level), preparative extraction of specific mRNA (and genes) and genomic research/mapping.
- genomic DNA libraries or cDNA libraries and the maintenance, and handling of these libraries are critical procedures in the field of genomics and/or biotechnology.
- classical libraries the relevant segments of DNA are cloned into vectors, which are maintained and propagated in particular biological systems (in vivo).
- libraries in vitro can be directly constructed from genomic DNA or cDNA. They contain linkers at the 5' and 3' ends of the DNA which allow PCR amplification of the library.
- the information stored in these libraries contains repetitive sequence elements that originated from repetitive DNA, or high copy mRNAs. This results in a significant redundancy, which can complicate the use and the outcome of using classical libraries.
- Another important feature which reduces the utility of classical libraries is the heterogeneity in size of the members comprising the library.
- a number of diagnostic methods that involve nucleic acid hybridization have arisen in recent years. Most of them are designed to provide qualitative information about the presence of a specific sequence motif in a complex analytical mixture of nucleic acids and use a detection system based on PCR and/or DNA chip hybridization technologies (3-7). For both of these technologies, diagnostic oligonucleotides constitute an essential part of the detection system. These oligonucleotides are primarily chosen based on the sequence data of the nucleic acids to be detected. In spite of the power of hybridization to correctly identify a complementary strand, it does face limitations. In fact, the difference in stability between a perfectly matched complement and a complement mismatched at only one base can be as little as 0.5° C (8).
- Akopyants et al (7) performed subtractive hybridization using bacterial DNAs digested by high-frequency restriction enzymes.
- the use of such restriction enzymes tends to generate DNA fragments having a broadly similar size, about 500 base pairs.
- the uniformity is not rigorous.
- the library created by these restriction fragments still contains a significant number of redundant sequences; consequently, patches of short polymorphism embedded in homologous sequences are going to be missed when such a library is used.
- U.S. Patent No. 5,270,163 (8) teaches a method for the isolation of nucleic acids using high-affinity nucleic acid ligands.
- This method has been termed the SELEX method (Systematic Evolution of Ligands by Experimental Enrichment) and is based on the use of proteins or small molecules, but not nucleic acids, as targets.
- the selection of oligonucleotides in the SELEX method relies on the three-dimensional (3D) shape of the oligonucleotides and their fit into the structures of the target molecules. In contrast to this, the selection of oligonucleotides in the present invention is based on hybridization with target nucleic acid.
- Armour et al (11) describes the quantitative recovery of amplifiable probes hybridised to an immobilised target.
- the amplifiable probes consist of PCR or restriction fragments and their technique is meant to assess the copy number of loci.
- oligonucleotide libraries which allow for the use of uniform hybridization conditions to perform selection and/or subtraction while minimizing or eliminating redundant sequences.
- these libraries can be used in the selection of highly informative and target-specific probe libraries. The present invention seeks to meet these and other needs.
- oligonucleotide probes with a high specificity for a given system.
- These oligonucleotides cover the entire length of the target DNA, thus increasing detectability which might be lost in classical oligo-detection systems due to secondary DNA structure or DNA deletions present in an analyte mixture.
- they present inexpensive variants of a multiplex oligonucleotide-detection approach, since they are not required to be individually synthesized.
- a process for the generation of oligonucleotide libraries, or OLs there is provided a process for the generation of oligonucleotide libraries, or OLs.
- the present invention teaches a process for generating OLs from genomic DNAs and cDNAs, and for performing the subtraction of these libraries.
- the present invention further teaches OLs which allow the use of hybridization conditions which are controllable and reproducible.
- the invention teaches a process for the selection of uniform length OLs which minimizes or eliminates redundant sequences and reduces complexity. The result is the production of highly-informative and target-specific probe libraries.
- An object of the present invention is therefore to provide a process for the generation of oligonucleotide libraries comprising OLs of uniform length which are self-amplifiable and easily subjected to subtraction.
- Another object of the invention is to provide OLs which are compatible with DNA array technology. Indeed, an array of diverse mixtures of oligonucleotides which show differential hybridization patterns could be the best choice for the next generation of DNA diagnostics.
- Figure 1 Schematic representation of the experimental procedure for the preparation of OL.
- Denatured DNA is bound to the membrane and hybridized to the random oligonucleotides library in the presence of blockers. Theses blocking primers disallow the unspecific hybridization of left and right oligonucleotide arms used for PCR amplification of the OL. (ss - single-stranded DNA, ds - double-stranded DNA). Hybridization and PCR amplification of OL are described more particular below, in the Experimental Methods.
- Figure 2 Dot blot hybridization of OL targeted against different genomes.
- the first row represents the dot blot hybridization of random probes with the specified genomic DNA (adenovirus, pBluescript and lambda).
- the last row shows dot blot hybridization of mixed adenovirus and lambda- selected OL.
- the other rows are analytical dot blot hybridizations of selected OLs with each of the genomes indicated. The procedures of preparative and analytical hybridization are described in the Experimental Methods, below.
- Figure 3 Specificity and probe distribution of OL generated from adenoviral genome.
- A The corresponding genome and adenoviral DNA were run on a 1 % agarose gel stained with ethidium bromide. The type of restriction enzyme and DNA are indicated on the top of each gel lane.
- B Southern hybridization of the same gel using adenovirus OL as an hybridization probe (see Figure 2, row 2). It should be noted that under the experimental conditions, there was no cross-hybridization with either lambda or human DNA.
- C The same membrane was stripped and rehybridized with a OL directed against a 3648 bp-long restriction fragment.
- adenovirus OL was prepared by cutting the membrane corresponding to the 3648 bp band from a similar southern blot and reamplified by PCR as described in the Experimental Methods, below. Thus, it is shown that OL specificity may be enhanced by controlling the choice of targeted DNA fragments in the next round of selection.
- Figure 4 The distribution of OL along genomic DNA.
- the densitrometric scan of radioactive signal from OL was integrated over total adenoviral genome ( Figure 3, lanes 3 and 5) using Scion Image software (Scion corporation, Frederick, Maryland).
- the signal intensity of OL probes hybridizing to restriction fragments is linearly proportional to the length of DNA.
- Figure 5 Subtractive enrichment of OL.
- the tester OL is presented by the mixture of two genomes (Adenovirus type 2 and Lambda phage).
- the driver OL was produced from the Lambda genome only.
- the single stranded (ss) OL from driver DNA was used to pool out the complementary single stranded mixed tester OL.
- the remainder of the mixed OL was used as a probe in the analytical hybridization step.
- the mixed OL probes were analyzed by dot blotting as described (B) before subtractive enrichment and (C) after subtractive enrichment by hybridization to genomic Adenovirus and Lambda DNA.
- Figure 6 Relative distribution of 20-mers with the different number of mismatches which do hybridize to targeted DNA.
- the abscissa shows the number of mismatches present in the 20-mer, while the y-axis illustrates the corresponding relative frequencies.
- the distribution profile was obtained by calculating the number of combinations for each particular number of mismatches which are thermostable at 52° C.
- the y-axis was normalized to reflect the relative distribution (%) over the total number of captured oligonucleotides (100%). The majority of n-mers captured after the first round of selection will be 20-mers with less then 6 mismatches. This is described further in the Detailed Description, below.
- a uniform length of about 60 bases comprising a central segment of about 20 bases randomly varied to represent all possible combinations, and segments of about 20 bases of a defined sequence flanking the central segment on each side;
- OLs enhances the specificity of hybridization to nucleic acids isolated from various sources, thereby allowing for the preparation of oligonucleotide mixtures useful in the detection and quantification of specific nucleic acids or nucleic acid mixtures.
- the starting pool of oligonucleotides is chemically synthesized and consists of a random region of a fixed length (L), flanked by a constant sequence (primer binding sites, PBS).
- the basic length of oligonucleotides is long enough to generate uniform sequence motifs for a particular biological system.
- the complexity of the library (10 12 ) overcomes the complexity of the template (which is usually between 10 4 -10 9 ).
- the random pool is then hybridized with a nucleic acid template isolated from any selected source and the unbound oligonucleotides are washed away under stringent conditions.
- the remaining, template-bound oligonucleotides are then subjected to amplification, using PCR or other methods known to those of skill in the art and using primers complementary to the constant flanking segments, thus producing a library of oligonucleotides capable of selectively hybridizing to nucleic acid templates.
- the choice of 20-mer for the length of the oligonucleotide library is not arbitrary but is based on the rationale that the length of the particular sequence motif should be long enough to be unique for even the most complex genomes.
- the L-mer of length L will be, on average, repeated every 4 power L base pairs. The longer the L, the greater the average distance between 2 identical sequence motifs of length L will be. However, this particular combinatorial approach is at best approximative, and other lengths may be suitable as well.
- the choice of length will depend on such factors as the length and/or complexity of the genome to be detected and compatibility with current nucleic acid amplification and DNA array technologies.
- the amplification described above is performed with one of the PCR primers being labelled with biotin, providing means for purification of the labelled products with streptavidin-labelled substrates (12) or other similar methods.
- the amplified mixture of unlabelled oligonucleotides specific to one template is hybridized with labelled mixtures of oligonucleotides selected for specificity to one or several nucleic acid templates, and the unbound material is collected. In this manner, a mixture of nucleotides which is enriched for nucleic acids present in the unlabelled library only can be generated.
- the process is based on stringent hybridization. Furthermore, high fidelity hybridization between pools of oligonucleotides and templates (genomic DNA or cDNA) is the basic mode of transfer of genomic information into OLs. An efficient subtractive hybridization procedure is used to accommodate the features of the aforementioned OLs.
- the starting random DNA pool was synthesised by GIBCO BRL (Burlington, Canada), (RAN), 5'-GCCTGTTGTGAGCCTCCTGTCGAA- N 20 -TTGAGCGTTTATTCTTGTCTCCC-3'.
- the corresponding left and right arms were (LEFT) 5'-GCCTGTTGTGAGCCTCCTGTCGAA-3' and (RIGHT) 5'-BioGGGAGACAAGAATAAACGCTCAA-3'.
- the 5'-end biotinylated oligonucleotides were used to pool out complement strands, using BioMag magnetic particles (PerSeptive Biosystems, Framingham, MA ).
- genomic DNA was used to produce OL: Adenovirus DNA Type 2, (GIBCO BRL), Lambda DNA cl857 indl Sam 7 (New England Biolabs), pBluescript II SK(+) (Stratagene. San Diego, CA).
- the Human HeLa DNA used as one control was from Clontech (Palo Alto, CA). Blotting genomic DNA
- the genomic DNA was denatured 2-3 minutes at 95° C and cooled on ice.
- the nylon membrane (Hybond-N, Amersham Pharmacia Biotech, Piscataway, NJ) was blotted with 100 ng of denatured genomic DNA, dried for 2 minutes on a hot plate and exposed to UV light for 8 minutes.
- the prehybridization was done for a minimum of 30 minutes in the hybridization buffer (7% SDS, 0.25M Na2HPO4 pH7.4, 1mM EDTA, pH 8.0 and 10g/L of BSA).
- the preparative hybridization between random core (20N) and targeted DNA was done with 10 pmoles of starting random pool (RAN).
- the random pool was pre-mixed with 100 pmoles (10 times more than RAN) of LEFT and RIGHT blockers in order to exclude cross-hybridization of left and right arms with genomic DNA.
- the oligonucleotide mixture was heated up to 95°C, cooled at room temperature and added to the hybridization buffer.
- the hybridization was done overnight at 50° C.
- the first washing was done with 6X SSC, followed by subsequent 2X SSC washing at the same temperature as hybridization was done.
- the dot containing the genomic DNA and bound probes was cut out of the nylon membrane (radius of 2-4mm), soaked in 100 ⁇ l H 2 0 and heated to 95°C for 1-2 minutes.
- the solution containing the denatured probe originally RAN was then collected and passed threw a Sephadex G-50 column in order to eliminate salts and SDS.
- the PCR was prepared under standard conditions, typical for SELEX-like amplification of DNA (10, 13).
- the RIGHT 5'-end biotinylated primer of the sense strand (the one which did not hybridise with genomic DNA) and LEFT primer of antisense strand were used in the PCR reaction.
- the temperature cycles were 53°C, 72°C, 95°C, each 30 seconds, repeated 20 times.
- Probe labelling and hybridization Before labelling, the PCR reaction mixtures were passed threw Sephadex G-50 columns. Around 100-200 ng of PCR product was labelled with 50 pmols of ⁇ P 32 ATP (6000 Ci/mmol, I.C.N. pharmaceuticals, Irvine, CA). The total amount of probe radioactivity was 300 000 c.p.m. The probe was added into 0.5 ml of hybridization buffer. The blotting of genomic DNA was done as described above. Hybridizations were done overnight at 50°C. The nylon membrane was washed as previously described, and exposed to Kodak X-OMAT film.
- the generated OL was tested, using 1) the original genomic DNA from which they were selected (positive control) and 2) using the unrelated genomic DNA (negative control).
- the OL labelling, hybridization and probe washing was done as described, except that hybridization time was shorter (60 minutes).
- Electrophoresis was performed in a 1 % agarose gel with TBE buffer (80 mM Tris borate, pH 8.0, 2mM Na 2 EDTA) and stained with ethidium bromide.
- TBE buffer 80 mM Tris borate, pH 8.0, 2mM Na 2 EDTA
- One ug of BstEII-digested lambda DNA, 300 ng of adenoviral DNA and 1 ⁇ g of Alul-Hpal-digested human HeLa DNA were run on the gel according to specifications (all restriction enzymes used in this work were purchased from New England Biolabs).
- DNA was transferred to Nylon membranes by capillary blot procedure following manufacturer's recommendations (Amersham Pharmacia Biotech). Hybridization was performed as described above with adenoviral OL. Autoradiographic exposure (using Kodak X-OMAT film) was done at room temperature, for few hours. Stripping of the membrane was done by boiling a 1% SDS solution and pouring it
- the tester OL (mixed OL) that reflects the two genomes (Adenovirus type 2 and Lambda) was made by preparing OL from equimolar mixtures of 2 genomes.
- the driver OL was produced from the lambda genome only.
- the production of sense strand (the one which did not hybridize with genomic DNA) was done using 5'-end biotinylated primer in PCR reaction. After denaturing PCR product, the biotinylated sense strand was bound to streptavidin magnetic particles (200 ⁇ g, binding capacity > 200 pmols of biotinylated oligonucleotides, Biomag Magnetic Particles, PerSeptive Biosystems), and pulled-out using a magnet.
- the complementary antisense strand was discarded with the liquid phase.
- the mixed antisense tester OL (Lambda + Adenovirus DNA) was produced in the same way. This time, the supernatant with the antisense, non-biotinylated strand was hybridized overnight at 50°C with 10 times molar excess of driver Lambda sense stand attached to magnetic beads.
- the hybridization buffer was the same as described above but without SDS. After removing the fraction bound to the magnetic beads, the rest of the mixture was used in the analytical hybridization step.
- the starting random pool of oligonucleotides contains 4 20 (i.e. 10 12 ) different 20-mers.
- the diversity of the sequence motifs is approximately 10 11 higher than the diversity of the most complex genomes.
- a schematic representation of the procedure for generating OL is presented in Figure 1 and is described in detail in the Experimental Methods, above.
- Blockers were used in order to avoid hybridization of the flanking arms to the targeted genome, and this step was found to be critical to achieve specificity.
- the stringency of hybridization conditions eliminates unbound 20-mers, leaving the specific oligonucleotides bound to the membrane via hybridization of the random core to the genome (Fig. 1). This ensemble of selected oligonucleotides constitutes the OL.
- the starting random pool of oligonucleotides contained about 8 copies of each sequence motif during the first hybridization step (10-20 pmoles) and that the number of copies of each particular 20-mer present in the random mixture was smaller than the number of genome copies.
- Figure 2 shows that OLs are able to discriminate genomes with complexities around 10 3 to 10 4 .
- the starting random pool of probes binds to all three genomes equally (Fig. 2, row 1).
- the OL can hybridise specifically towards a single targeted genome (Fig. 2, rows 2, 3 and 4).
- the OL can be selected against a mixture of two genomes and the specificity is conserved for both genomes (Fig. 2, row 5).
- a Southern blot was performed in order to document the distribution of adenovirus OL probes along the genome (Fig. 3). There was no apparent cross-hybridization of adenovirus OL to either HeLa or Lambda DNA (Fig. 3b, lanes 1 , 4, 5 and 6). The intensity of radioactive signal over adenoviral genome generated by adenovirus-specific OL was linearly increasing with the DNA fragments' length (Fig. 4). Therefore, one could deduce a uniform distribution of OL throughout the genomic DNA.
- Fig. 5a One round of subtractive enrichment between two oligonucleotide libraries was performed as schematized (Fig. 5a).
- the tester OL reflects the two genomes (adenovirus type 2 and lambda phage).
- the driver OL was produced from the Lambda genome only.
- the single stranded (ss) OL from the driver DNA was used to pool out the complementary single stranded, mixed, tester OL.
- the rest of ssDNA was used as a probe in the analytical hybridization step.
- the intensity of hybridization signals between Lambda and Adeno genomes, before (Fig. 5b) and after ( Figure 5c) one round of subtractive enrichment was shown. It should be noted that further subtraction steps could be performed by changing the sequence design of flanking arms between tester and driver OLs, as suggested by recent developments in subtractive procedures (14).
- the relative distribution of 20-mers with different numbers of mismatches that hybridized to the targeted DNA was predicted.
- the number of combinations of 20-mers (C) with the same number of mismatches (m) in the initial random pool of oligonucleotides that are capable of hybridizing to a specific 20-mer motif was calculated. Since each full match could be replaced by 3 different mismatches, the number of combinations must be multiplied by 3 m i.e. C * 3 m .
- the process described herein generates probes with high detection power. These probes/selected oligonucleotides can contain mismatches.
- the notion that introduction of artificial mismatches could increase detection power of oligonucleotides during single nucleotide polymorphism (SNP) detection was well documented by Guo et al (6).
- SNP single nucleotide polymorphism
- the prediction of positions and types of mismatches, which should be introduced to increase detectability of oligonucleotide remains undefined. Consequently, to enhance oligonucleotide detectability by introducing (artificial) mismatches, one must search different positions and types of mismatches along the oligonucletide. Once they are empirically determined, i.e.
- the oligonucleotide containing particular mismatches could be used (15).
- the present process provides an approach based on differential selection of thermostable oligonucleotides (i.e. their differential stability), which are present in one, but not in the second system.
- the selection of oligonucleotides with the highest detectability is inherently present in this process, i.e. the method suggests a solution to the problem of where and what type of mismatches should be introduced to increase detection power of oligonucleotide, or to find the particular oligonucleotide which best discriminates between 2 sequence motifs which may differ by a single base.
- the number of 20-mers both in the targeted genome and the probe mixture (OL) could be adjusted.
- Each new round of preparative hybridization (Fig.1) and/or subtraction (Fig. 6) could reduce the complexity of OL, by using the excess OL rather than genomic DNA. Therefore, the average number of mismatches for each particular 20-mer will continue to decline until it reaches the sequence-dependent limitation, but not the concentration-dependent limitation.
- OLs are generated from the template DNAs. These OLs are used in subtractive hybridization, for example between genomic or cDNA- based libraries (OL1 and OL2) to make a new Subtractive Oligonucleotide Library (SOL1/2 and/or SOL2/1)), that is/are specific for one system/library but not for the other. Oligonucleotides isolated from such subtractive libraries (SOL) are useful for diagnostic purposes. They can a) directly serve as highly specific hybridization probes or b) they can be tested for PCR-specific differential amplification, specific for one, but not the other biological system.
- each OL produces an image which is specific for the templated DNA (genome or cDNA).
- a particular advantage in using OL or SOL instead of genomic/cDNA libraries is that the hybridization signal is not dependent on copy number and distribution of particular sequence motifs.
- OLs or SOLs can be inferred from two biologically relevant systems, like mammalian cells, to detect fine differences in cell cycle, tissue status, viral infection, age/development status etc.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00900999A EP1144683A1 (en) | 1999-01-19 | 2000-01-19 | Process for the generation of oligonucleotide libraries (ols) representative of genomes or expressed mrnas (cdnas) and uses thereof |
CA002360567A CA2360567A1 (en) | 1999-01-19 | 2000-01-19 | Process for the generation of oligonucleotide libraries (ols) representative of genomes or expressed mrnas (cdnas) and uses thereof |
AU20879/00A AU2087900A (en) | 1999-01-19 | 2000-01-19 | Process for the generation of oligonucleotide libraries (ols) representative of genomes or expressed mrnas (cdnas) and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2,259,745 | 1999-01-19 | ||
CA 2259745 CA2259745A1 (en) | 1999-01-19 | 1999-01-19 | Generation of oligonucleotide libraries representative of genomes or expressed mrnas (cdnas) and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000043538A1 true WO2000043538A1 (en) | 2000-07-27 |
Family
ID=4163211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2000/000047 WO2000043538A1 (en) | 1999-01-19 | 2000-01-19 | PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1144683A1 (en) |
AU (1) | AU2087900A (en) |
CA (1) | CA2259745A1 (en) |
WO (1) | WO2000043538A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000053804A2 (en) * | 1999-03-05 | 2000-09-14 | The University Of Nottingham | Genetic screening |
EP1164201A1 (en) * | 2000-06-14 | 2001-12-19 | Facultés Universitaires Notre-Dame de la Paix | Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
WO2002024950A2 (en) * | 2000-09-25 | 2002-03-28 | Neuromics Inc. | Methods and means of rna analysis |
WO2008017162A1 (en) * | 2006-08-11 | 2008-02-14 | Chu Sainte-Justine, Le Centre Hospitalier Universitaire Mere-Enfant | Oligonucleotides for discriminating related nucleic acid sequences |
US7338763B2 (en) | 2004-06-02 | 2008-03-04 | Eppendorf Array Technologies S.A. | Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109457018A (en) * | 2018-12-12 | 2019-03-12 | 上海迈景纳米科技有限公司 | A kind of EGFR mutated gene detection method based on multiple fluorescence PCR |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019813A1 (en) * | 1990-06-11 | 1991-12-26 | The University Of Colorado Foundation, Inc. | Nucleic acid ligands |
WO1993004204A1 (en) * | 1991-08-23 | 1993-03-04 | Isis Pharmaceuticals, Inc. | Synthetic unrandomization of oligomer fragments |
WO1996034875A1 (en) * | 1995-05-03 | 1996-11-07 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
WO1997013877A1 (en) * | 1995-10-12 | 1997-04-17 | Lynx Therapeutics, Inc. | Measurement of gene expression profiles in toxicity determination |
WO1997027317A1 (en) * | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
WO1998015651A1 (en) * | 1996-10-04 | 1998-04-16 | Brax Genomics Limited | Identifying antisense oligonucleotide binding |
WO1998015649A1 (en) * | 1996-10-04 | 1998-04-16 | Universität Heidelberg | A method of purifying dna |
WO1998026098A1 (en) * | 1996-12-13 | 1998-06-18 | Arcaris, Inc. | Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom |
WO1998042871A1 (en) * | 1997-03-24 | 1998-10-01 | Boehringer Mannheim Corporation | Procedure for subtractive hybridization and difference analysis |
WO1999028497A1 (en) * | 1997-12-02 | 1999-06-10 | Polygene Inc. | Selective technique for rapid identification of proteins and genes and uses thereof |
-
1999
- 1999-01-19 CA CA 2259745 patent/CA2259745A1/en not_active Abandoned
-
2000
- 2000-01-19 AU AU20879/00A patent/AU2087900A/en not_active Abandoned
- 2000-01-19 EP EP00900999A patent/EP1144683A1/en not_active Withdrawn
- 2000-01-19 WO PCT/CA2000/000047 patent/WO2000043538A1/en not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019813A1 (en) * | 1990-06-11 | 1991-12-26 | The University Of Colorado Foundation, Inc. | Nucleic acid ligands |
WO1993004204A1 (en) * | 1991-08-23 | 1993-03-04 | Isis Pharmaceuticals, Inc. | Synthetic unrandomization of oligomer fragments |
WO1996034875A1 (en) * | 1995-05-03 | 1996-11-07 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
WO1997013877A1 (en) * | 1995-10-12 | 1997-04-17 | Lynx Therapeutics, Inc. | Measurement of gene expression profiles in toxicity determination |
WO1997027317A1 (en) * | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
WO1998015651A1 (en) * | 1996-10-04 | 1998-04-16 | Brax Genomics Limited | Identifying antisense oligonucleotide binding |
WO1998015649A1 (en) * | 1996-10-04 | 1998-04-16 | Universität Heidelberg | A method of purifying dna |
WO1998026098A1 (en) * | 1996-12-13 | 1998-06-18 | Arcaris, Inc. | Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom |
WO1998042871A1 (en) * | 1997-03-24 | 1998-10-01 | Boehringer Mannheim Corporation | Procedure for subtractive hybridization and difference analysis |
WO1999028497A1 (en) * | 1997-12-02 | 1999-06-10 | Polygene Inc. | Selective technique for rapid identification of proteins and genes and uses thereof |
Non-Patent Citations (3)
Title |
---|
ARMOUR ET AL.: "MEASUREMENT OF LOCUS COPY NUMBER BY HYBRIDISATION WITH AMPLIFIABLE PROBES", NUCLEIC ACIDS RESEARCH, vol. 28, no. 2, 2000, pages 605 - 609, XP002138423 * |
GENG ET AL.: "ISOLATION OF DIFFERENTIALLY EXPRESSED GENES BY COMBINING REPRESENTATIONAL DIFFERENCE ANALYSIS (RDA) AND CDNA LIBRARY ARRAYS", BIOTECHNIQUES,US,EATON PUBLISHING, NATICK, vol. 25, no. 3, 5 September 1998 (1998-09-05), pages 434 - 438, XP002916349, ISSN: 0736-6205 * |
SEDLACEK ET AL.: "Direct selection of DNA sequences conserved between species", NUCLEIC ACIDS RESEARCH, vol. 21, no. 15, 1993, pages 3419 - 3425, XP002138409 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000053804A2 (en) * | 1999-03-05 | 2000-09-14 | The University Of Nottingham | Genetic screening |
WO2000053804A3 (en) * | 1999-03-05 | 2000-12-21 | Univ Nottingham | Genetic screening |
EP1164201A1 (en) * | 2000-06-14 | 2001-12-19 | Facultés Universitaires Notre-Dame de la Paix | Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
WO2001096592A2 (en) * | 2000-06-14 | 2001-12-20 | Facultes Universitaires Notre-Dame De La Paix | Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
WO2001096592A3 (en) * | 2000-06-14 | 2002-04-11 | Univ Notre Dame De La Paix | Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
WO2002024950A2 (en) * | 2000-09-25 | 2002-03-28 | Neuromics Inc. | Methods and means of rna analysis |
WO2002024950A3 (en) * | 2000-09-25 | 2002-12-05 | Neuromics Inc | Methods and means of rna analysis |
US7338763B2 (en) | 2004-06-02 | 2008-03-04 | Eppendorf Array Technologies S.A. | Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays |
WO2008017162A1 (en) * | 2006-08-11 | 2008-02-14 | Chu Sainte-Justine, Le Centre Hospitalier Universitaire Mere-Enfant | Oligonucleotides for discriminating related nucleic acid sequences |
Also Published As
Publication number | Publication date |
---|---|
AU2087900A (en) | 2000-08-07 |
EP1144683A1 (en) | 2001-10-17 |
CA2259745A1 (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2121977T3 (en) | Capture (4C) OF CHROMOSOMES WITH CIRCULAR CONFORMATION | |
EP1634963B1 (en) | Method of nucleic acid amplification using immobilised colony primers | |
US6225077B1 (en) | Method for characterizing DNA sequences | |
US20090305237A1 (en) | Quantification of nucleic acids and proteins using oligonucleotide mass tags | |
EP2476760A1 (en) | Method for analyzing nucleic acid mutation using array comparative genomic hybridization technique | |
EP1711631A1 (en) | Nucleic acid characterisation | |
KR20020008195A (en) | Microarray-based analysis of polynucleotide sequence variations | |
JP5663491B2 (en) | Target nucleic acid detection method | |
EP1612282B1 (en) | Probe set and substrate for detecting nucleic acid | |
US20030152931A1 (en) | Nucleic acid detection device and method utilizing the same | |
EP1639126A2 (en) | Regulome arrays | |
WO2000043538A1 (en) | PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF | |
JP2004520838A (en) | Methods for detecting nucleic acid molecules | |
EP4108783B1 (en) | Spatial sequencing with mictag | |
US7371516B1 (en) | Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization | |
EP1200625A1 (en) | Methods for determining the specificity and sensitivity of oligonucleotides for hybridization | |
US8313905B2 (en) | Detection oligomer and method for controlling quality of biochip using detection oligomer | |
CA2360567A1 (en) | Process for the generation of oligonucleotide libraries (ols) representative of genomes or expressed mrnas (cdnas) and uses thereof | |
Baldocchi et al. | Design considerations for array CGH to oligonucleotide arrays | |
Brukner et al. | Generation of amplifiable genome-specific oligonucleotide probes and libraries | |
WO2002052037A2 (en) | Method for screening and/or identifying factors that bind to nucleic acids | |
JP2005087116A (en) | Nucleic acid molecule specific to mouse gene | |
CA2284481A1 (en) | Method of producing a subtraction library |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000900999 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2360567 Country of ref document: CA Kind code of ref document: A Ref document number: 2360567 |
|
WWP | Wipo information: published in national office |
Ref document number: 2000900999 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000900999 Country of ref document: EP |